Dimopoulos M, Tedeschi A, Trotman J, et al. Multinational, randomized phase 3 trial of ibrutinib-rituximab vs placebo-rituximab with Waldenström’s macroglobulinemia. EHA 2018, abstract S852.
THEMIS2-expressie verbetert voorspelling time-to-first-treatment bij CLL
jan 2024 | Leukemie